Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2023-04-28 | John C. Jacobs President and Chief Executive Officer (January 2023 to present) Age 56 COMMITTEES None |
| 2024-04-29 | John C. Jacobs President and Chief Executive Officer (January 2023 to present) Mr. Jacobs is well-suited to serve on our Board due to his leadership experience in the biotechnology industry, having held several leadership position for commercial biotechnology companies. The Company does not pay employee directors additional compensation for service on the Board. Summary Compensation Table: Total compensation $7,301,009. |
Data sourced from SEC filings. Last updated: 2026-02-03